Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Astria Therapeutics, Inc. (ATXS)
|
|
Balance Sheet |
|
|
|
Standardized | As Reported |
Annual | Quarterly |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Assets |
Cash and equivalents | 134.0 | 202.3 | 20.5 | 46.0 | 29.8 | 46.7 | 86.5 | 131.8 |
Short-term investments | 69.0 | 11.0 | 205.9 | 70.6 | 72.7 | 66.1 | 39.0 | |
Other current assets | 1.5 | 2.1 | 1.3 | 1.9 | 1.3 | 1.4 | 1.6 | 2.7 |
Total current assets | 204.4 | 215.4 | 227.7 | 118.5 | 103.8 | 114.2 | 127.1 | 134.5 |
Other fixed assets | 2.0 | 2.0 | 2.0 | 0.2 | 0.2 | 0.2 | 0.0 | 0.1 |
Total assets | 207.1 | 218.2 | 230.6 | 119.8 | 105.3 | 114.7 | 127.5 | 135.1 |
|
Accounts payable | 0.8 | 0.9 | 0.8 | 0.8 | 1.0 | 0.9 | 1.6 | 0.6 |
Accrued expenses | 5.2 | 5.2 | 7.7 | 5.1 | 3.7 | 3.9 | 3.3 | 3.6 |
Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Other current liabilities | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.2 | 0.4 | 0.5 |
Total current liabilities | 6.6 | 6.7 | 9.1 | 6.4 | 5.2 | 5.0 | 5.2 | 4.7 |
Other liabilities | 0.1 | 0.2 | 0.4 | 0.5 | 0.6 | | | |
Total liabilities | 6.7 | 6.9 | 9.4 | 6.9 | 5.9 | 5.0 | 5.2 | 4.7 |
|
Shareholders' equity [+] | 200.4 | 211.4 | 221.2 | 112.9 | 99.4 | 109.7 | 122.3 | 130.4 |
Paid-in capital | 636.4 | 634.8 | 632.5 | 511.1 | 485.6 | 484.5 | 481.7 | 480.3 |
Retained earnings | -531.4 | -518.8 | -507.6 | -494.4 | -482.4 | -471.1 | -455.8 | -446.3 |
Tangible shareholders' equity | 200.4 | 211.4 | 221.2 | 112.9 | 99.4 | 109.7 | 122.3 | 130.4 |
|